US Flag logoAn official website of the United States government
Acute Myeloid Leukemia (AML)
TARGET
Data Resource:  TARGET
Point of Contact:  
Center for Cancer Genomics,  
Project

About This Dataset
The TARGET Acute Myeloid Leukemia projects elucidate comprehensive molecular characterization to determine the genetic changes that drive the initiation and progression of high-risk or hard-to-treat childhood cancers. Acute myeloid leukemia (AML) is a cancer that originates in the bone marrow from immature white blood cells known as myeloblasts. About 25% of all children with leukemia have AML.
Core Data Elements
Number of Cases
2,146
Case Sex
Female (1,022); Male (1,124)
Case Age At Diagnosis
0 to 4 years (657); 5 to 9 years (393); 10 to 14 years (547); 15 to 19 years (490); 20 to 24 years (49); 25 to 29 years (10)
Case Race
American Indian or Alaska Native (13); Asian (97); Black or African American (250); Native Hawaiian or other Pacific Islander (9); White (1,541); Not Reported (110); Unknown (126)
Case Ethnicity
Hispanic or Latino (385); Not Hispanic or Latino (1,615); Not Reported (20); Unknown (126)
Case Disease Diagnosis
Acute Myeloid Leukemia, NOS (2,146)
Case Tumor Site
Blood (2,146)
Additional Data Elements
DBGAP STUDY IDENTIFIER
DATA REPOSITORY
Grant Information
261200800001E-12-0-40
Therapeutically Applicable Research to Generate Effective Treatments (TARGET)
HHSN261200800001E
NCI Contract
U10CA180886
COG NCTN Network Group Operations Center
Published In
https://www.cancer.gov/ccg/research/genome-sequencing/target/publications?field_publication_project_target_id_selective=18&items_per_page=10#acute-myeloid-leukemia-aml
Charts
Male (1,124); Female (1,022)
1,124Male